Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07471230 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism

Study acronym: STEM-PARK
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This clinical trial investigates the safety and therapeutic potential of mesenchymal stem cell-based therapies in patients with parkinsonism. The study evaluates neuroinduced mesenchymal stem cells and mesenchymal stem cell-derived exosomes as potential regenerative treatments targeting neurodegeneration within dopaminergic pathways.
Trial Details
NCT Number NCT07471230
Lead Sponsor Biocells Medical
Conditions
(from sponsor)		 Parkinsonism or Parkinson's Disease Nos, Parkinsonism in Diseases Classified Elsewhere
Related terms Parkinson Disease, Parkinsonian Disorders
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov